K2 Infused Paper (Synthetic Cannabinoid Blotter)
Price range: $80.00 through $2,000.00
Product Identifier: Perforated Blotter Paper Infused with Synthetic Cannabinoid Receptor Agonists (SCRAs)
Appearance: Standard sheet of white, matte blotter paper (approx. 7.5cm x 7.5cm) divided into a grid of small, perforated squares. May bear abstract designs or be blank.
Formulation: Precise micro-doses of a potent synthetic cannabinoid (e.g., 5F-ADB, MDMB-4en-PINACA) evenly distributed via volatile solvent onto absorbent paper.
Dosage per Square: Highly variable and unknown, typically estimated between 0.5mg – 2mg of active SCRA, a potentially dangerous dose.
Description
K2 Infused Paper is a novel and particularly hazardous delivery format for synthetic cannabinoids, modeled after LSD blotter. This product consists of a sheet of high-quality blotter paper that has been uniformly soaked in a concentrated solution of potent SCRAs and then dried. Each tiny, perforated square represents a single dose, designed for sublingual (under the tongue) administration. The paper format is marketed for its extreme discreteness, ease of transport, and perceived “precision.” However, unlike LSD, the margin of safety for synthetic cannabinoids is virtually nonexistent, and even slight inconsistencies in the soaking process can create squares of lethally different potencies.
Key Attributes & Administration:
The intended use is sublingual absorption: a single square is placed under the tongue and held there until the paper softens and dissolves, allowing the compound to enter the bloodstream via the mucous membranes. Onset via this route can be rapid (15-30 minutes). This method is exceptionally dangerous due to the inability to verify dosage, the delayed onset preventing timely intervention, and the extreme potency of the active compounds. Effects are those of a full CB1 receptor agonist: unpredictable and potentially including severe anxiety, hallucinations, psychosis, tachycardia, seizures, and vomiting.
Composition & Critical Warnings:
-
Unverified and Dangerous Dosage: There is no reliable way for an end-user to know the dose on any given square. One square could be inert, the next could cause a life-threatening overdose.
-
Delayed Onset Increases Risk: The sublingual route prevents immediate effect feedback, leading users to potentially re-dose into a catastrophic overdose.
-
Not for Human Consumption: This product is a dangerous research chemical in a dangerously accessible form.
-
Extreme Toxicity: The SCRA compounds used are linked to organ toxicity, including kidney and liver damage, with chronic use.
Packaging & Supply:
Sheets are shipped flat, sandwiched between cardboard or sealed in mylar bags to prevent moisture damage. Sourced from niche labs experimenting with novel delivery methods for SCRAs. This product represents one of the most irresponsible and high-risk formats available, combining unknown dosage with some of the most toxic psychoactive compounds known.
Reviews
There are no reviews yet.